Laboratory medicine: The exemplar for value-based healthcare

Abstract

Value-Based Healthcare (VBHC) aims to improve the overall quality, safety, and sustainability of healthcare while reducing delivery costs of more effective care. Despite advantages associated with VBHC transformation, the road to its adoption has been lengthy. Laboratory Medicine (LM) is in a prime position to lead the transition to VBHC because of its key role in diagnosis and treatment of patients. Laboratory medicine results inform/influence 50% to 70% of all clinical decisions. This article summarizes some issues associated with adoption of VBHC and related healthcare innovations and suggests potential approaches using LM-specific examples to help accelerate adoption. Laboratory medicine is both a useful model for VBHC implementation and facilitator for related innovation adoption by helping to target patient populations that would benefit most from specific interventions. The critical value of rapidly adopted diagnostic technologies used during the COVID-19 pandemic and economic recovery provide important insights about the need to embrace and accelerate VBHC implementation.

Get full access to this article

View all access options for this article.

References

Institut du Quebec. Adopting healthcare innovations in Quebec. Suggested alternative models briefing March 2017. Published 2019. Accessed March 26, 2019. Available at: https://www.institutduquebec.ca/docs/default-source/default-document-library/8704_adoptinghealthcare_idq_eng_br.pdf?sfvrsn=0

Pinney

. How Hockey Can Save Healthcare: A Principle-Based Approach to Reforming the Canadian Healthcare System. Lulu Publishing; 2017.

Horne

Katz

Sedman

. Four lessons for a successful switch to value-based healthcare. Published 2019. Accessed December 8, 2020. Available at: https://www.weforum.org/agenda/2019/03/four-lessons-for-successful-healthcare-transformation/

Arshoff

Henshall

Juzwishin

Racette

. Procurement change in Canada: an opportunity for improving system performance. Healthc Manage Forum. 2012;25(2):66–69.

Price

St. John

. The role of laboratory medicine in value-based healthcare. J Appl Lab Med. 2020;5(6):1408–1410.

Canadian Institute for Health Information (CIHI). Health care in Canada 2009: a decade in review. Published 2009. Accessed March 20, 2019. Available at: https://secure.cihi.ca/free_products?HCIC_2009_Web.e.pdf

Arshoff

. Assessing innovations: what is the optimal approach for healthcare organizations? Healthc Q. 2010;13(2):84–96.

Snowden

. Clinically integrated supply chain infrastructure in health systems: the opportunity to improve quality and safety. Healthc Q. 2018;21(3):19–23.

Arshoff

Knapp

. Larry Arshoff talks value-based procurement and the supply chain Healthcare Management Forum Blog. Accessed September 1, 2020. Available at: https://healthcaremanagementforum.wordpress.com/2020/04/02/larry-arshoff-talks-value-based-procurement-and-the-supply-chain/

10.

Government of Ontario. Ontario Building up Ontario. Ontario Budget 2015. Published 2015. Accessed December 8, 2020. Available at: https://www.fin.gov.on.ca/en/budget/ontariobudgets/2015/

11.

Health Quality Council of Alberta. Provincial Plan for Integrated Laboratory Services in Alberta. Accessed December 8, 2020. Available at: https://hqca.ca/wp-content/uploads/2018/05/Provincial_Plan_for_Integrated_Laboratory_Services_in_Alberta_FINAL_.pdf

12.

American Association for Clinical Chemistry. Laboratories. Accessed May 16, 2018. Available at: https://www.aacc.org/community/laboratories

13.

C.D. Howe Institute. What the doctor ordered: improving the use and value of laboratory testing. Published 2019. Accessed July 31, 2019. Available at: https://www.longwoods.com/articles/images/What%20the%20doctor%20ordered?%20report.pdf

14.

Amukele

Schroeder

. What is the value of clinical laboratory testing? J Appl Lab Med. 2017;1(1):339–341.

15.

Hiltunen

. Dispelling the 70% claim with laboratory’s true value. Med Lab Mgmt. 2017;6(8):8–12.

16.

Rohr

Binder

Dieterie

, et al. The value of in vitro diagnostic testing in medical practice: a status report. PLoS One. 2016;11(3):e0149856.

17.

Crawford

Shortorbani

Sharma

, et al. Improving American healthcare through “clinical lab 2.0”: a project Santa Fe report. Acad Pathol. 2017;4:1–8.

18.

Tran

Cavalcante

Lubner

, et al. Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Ther Adv Med Oncol. 2015;7(5):252–262.

19.

Perez

Olsen

Musick

, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014;69(3):216–225.

20.

Beckmann

Lew

. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities. Genome Med. 2016;8:134.

21.

Munoz

Campbell

Atmar

, et al. Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J. 1999;18:811–815.

22.

Beekmann

Engler

Collins

Canosa

Henderson

Freifeld

. Rapid identification of respiratory viruses: impact on isolation practices and transmission among immunocompromised pediatric patients. Infect Control Hosp Epidemiol. 1996;17:581–586.

23.

Barenfanger

Drake

Leon

Mueller

Troutt

. Clinical and financial benefits of rapid detection of respiratory viruses: an outcome study. J Clin Microbiol. 2000;38:2824–2828.

24.

Public Health Ontario. The story of COVID-19 testing in Ontario. Published 2020. Accessed December 8, 2020. Available at: https://www.publichealthontario.ca/en/about/blog/2020/story-COVID-19-testing-ontario

25.

Slater

Shields

Racette

Juzwishin

. The emergence of precision therapeutics: new challenges and opportunities for Canada’s health leaders. Healthc Manage Forum. 2015;28(6 suppl):S33–39.

26.

Tepper

. The “forgotten” fourth aim of quality improvement in healthcare—improving the experience of providers. CMAJ. Accessed December 9, 2020. Available at: https://cmajblogs.com/the-forgotten-fourth-aim-of-quality-improvement-in-healthcare-improving-the-experience-of-providers/

27.

Perlo

Balik

Swensen

Kabcenell

Landsman

Feeley

. IHI Framework for Improving Joy in Work. IHI White Paper. Institute for Healthcare Improvement; 2017.

28.

Hall-Flavin

Winner

Allen

, et al. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet Economics. 2013;23(10):535–548.

29.

Hall-Flavin

Winner

Allen

, et al. Using a pharmacogenomic algorithm to guide the treatment of depression. Transl Psychiatry. 2012;2(10):e172.

30.

Winer

Carhart

Altar

Allen

Dechairo

. A prospective, randomized, double-blind study assessing the clinical ipact of integrated pharmacogenomic testing for major depressive disorder. Discov Med. 2013;16(89):219–227.

31.

Winner

Allen

Altar

Spahic-Mihajloic

. Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl Psychiatry. 2013;3:e242.

32.

Tanner

Davies

Voudouris

, et al. Combinatorial pharmacogenomics and improved patient outcomes in depression: treatment by primary care physicians or psychiatrists. J Psychiatr Res. 2018;104:157–162.

33.

Pantanowitz

Sinard

Henricks

, et al. Validating whole slide imaging for diagnostic purposes in pathology. Guideline from the American Pathologists Pathology and Laboratory Quality Centre. Arch Pathol Lab Med. 2013;137:1710–1722.

34.

ISO 22870:2016 Point-of-care testing (POCT)—Requirements for quality and competence. Published 2016. Accessed December 8, 2020. Available at: https://www.iso.org/standard/71119.html

35.

Almagor

Temkin

Benenson

Fallach

Carmeli

. The impact of antibiotic use on transmission of resistant bacteria in hospitals: insights from an agent-based model. PLoS One. 2018;13(5):e0197111.

36.

Vasiliadis

Lesage

Adair

Wang

Kessler

. Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv. 2007;58(1):63–71.

37.

Conference Board of Canada. Unmet mental healthcare needs costing Canadian economy billions. Published 2016. Accessed December 8, 2020. Available at: https://www.conferenceboard.ca/press/newsrelease/16-09-01/Unmet_Mental_Health_Care_Needs_Costing_Canadian_Economy_Billions.aspx

38.

Tetu

Perron

Louahlia

Pare

Trudel

Meyer

. The Eastern Quebec telepathology network: a three-year experience of clinical diagnostic services. Diagn Pathol. 2014;9(suppl 1):S1.

39.

Crown

Finkelstein

Berndt

, et al. The impact of treatment-resistant depression on healthcare utilization and costs. J Clin Psychiatry. 2002;63(11):963–971.

40.

Health Canada. Coronavirus disease 2019 (COVID-19): epidemiology update. Accessed December 5, 2020. Available at: https://health-infobase.canada.ca/COVID-19/epidemiological-summary-COVID-19-cases.html

41.

Tetu

Fortin

Gagnon

Louahlia

. The challenges of implementing a “patient oriented” telepathology network: the Eastern Quebec Telepathology Project experience. Anal Cell Pathol (Amst). 2012;35(1):11–18.

42.

Delport

Strikwerda

Armstrong

Schaus

John

. MALDI-ToF short incubation identification from blood cultures is associated with reduced length of hospitalization and a decrease in bacteremia associated mortality. Eur J Clin Microbiol Infect Dis. 2017;36(7):1181–1186.

43.

Mitchell

Martin

Holmes

, et al. How hospitals reengineer their discharge processes to reduce readmissions. J Healthc Qual. 2016;38(2):116–126.

44.

Chadwick

Knapp

Sinclair

Arshoff

. Impact of a change management program in a medical device reprocessing department: a mixed methods study. Healthc Manage Forum. 2014;27(1):20–24.

45.

Lalla

Arshoff

. A mental health initiative to enhance schizophrenia treatment efficacy. Healthc Manage Forum. 2013;26(1):46–50.